Clinical Trial Update: CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of CD4 in combination with CHOP for non-cutaneous peripheral T-cell lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma
• T-cell Lymphoma

Drugs mentioned

• CD4 (CD4)
• CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)

Snippet

Sponsor: Emergent BioSolutions | Conditions: T-cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2021-04-21